Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Geratherm Medical (GME) Stock Price & Analysis

10 Followers

GME Stock Chart & Stats

€2.12-€0.01(-0.47%)
At close: 5:30 PM GMT+1
€2€2.25€2.5Aug 11Aug 25Sep 7Sep 21Oct 7Oct 19Nov 3
Day’s Range
EUR 2.12 - EUR 2.12
52-Week Range
EUR 1.95 - EUR 3.89
Previous Close
EUR 2.13
Volume
N/A
Average Volume (3M)
654
Market Cap
EUR 11.60M
Enterprise Value
EUR 7.55M
Total Cash (Recent Filing)
EUR 8.81M
Total Debt (Recent Filing)
EUR 2.19M
Price to Earnings (P/E)
―
Beta
0.57
Next Earnings
Apr 27, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Jul 27, 2026
Dividend Yield
4.72%

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Low leverage and a substantial equity base provide financial flexibility as the company manages its current downturn. This structure can reduce financing pressure, preserve capacity to support operations, and give management more resilience when allocating capital over the next several quarters.

Positive Cash Generation

Positive operating and free cash flow show that the business is still converting activity into cash despite its recent earnings weakness. That internally generated liquidity can help fund operations and product commercialization without relying entirely on additional borrowing.

Strong Gross Margin

A gross margin near 66.8% indicates meaningful value retained after direct costs, supporting the economics of Geratherm’s medical-device and consumer-health portfolio. If maintained, this margin provides a foundation for covering operating expenses and restoring profitability as revenue stabilizes.

Bears Say

Revenue Contraction And Losses

Sharp revenue weakness combined with a return to negative net margins undermines near-term earnings visibility and operating leverage. Lower sales make fixed operating costs harder to absorb, while continuing losses could constrain reinvestment and weaken the company’s ability to build durable earnings power.

Deteriorating Free Cash Flow

Although cash flow remains positive, the steep decline in free cash flow reduces confidence in the durability of current cash generation. Weaker conversion leaves less internally funded capacity for development, commercialization, and shareholder distributions if operating performance remains uneven.

Negative Returns On Equity

Negative ROE shows that the substantial equity base is currently producing losses rather than attractive returns. This signals weak capital efficiency and can become a persistent drag on value creation unless management restores operating profitability and improves earnings generated from existing resources.

GME FAQ

What was Geratherm Medical’s price range in the past 12 months?
Geratherm Medical lowest stock price was €1.95 and its highest was €3.89 in the past 12 months.
What is Geratherm Medical’s market cap?
Geratherm Medical’s market cap is €11.60M.
When is Geratherm Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Geratherm Medical’s earnings last quarter?
Geratherm Medical released its earnings results on Aug 27, 2026. The company reported -€0.08 earnings per share for the quarter.
Is Geratherm Medical overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Geratherm Medical pay dividends?
Geratherm Medical pays a Annually dividend of €0.1 which represents an annual dividend yield of 4.72%. See more information on Geratherm Medical dividends here
What is Geratherm Medical’s EPS estimate?
Geratherm Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Geratherm Medical have?
Geratherm Medical has 5,444,998 shares outstanding.
What happened to Geratherm Medical’s price movement after its last earnings report?
Geratherm Medical reported an EPS of -€0.08 in its last earnings report. Following the earnings report the stock price went up 0.806%.
Which hedge fund is a major shareholder of Geratherm Medical?
Currently, no hedge funds are holding shares in DE:GME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology